<p>Each graph was based on 10000 replicates. 3a Incremental cost-effectiveness scatter plots. 3b Cost effectiveness acceptability curves.</p
textabstractBackground Costly biologicals in palliative oncology are emerging at a rapid pace. For e...
<p>The cost-effectiveness scatterplot shows incremental costs (€) versus incremental effectiveness e...
<p>The figure shows the distribution of cost-effectiveness pairs on the cost-effectiveness plane.</p
<p>The figure displays the incremental HbA1c (x axis) and incremental cost (y axis) outcomes of 5,00...
Cost-effectiveness acceptability curve for regorafenib treatment in the overall sample.</p
<p>Cost-effectiveness acceptability curve showing the probability that golimumab with standard care ...
<p>Acceptability curves of the cost-effectiveness at the different ceiling threshold of four treatme...
<p>Scatter plot of incremental cost-effectiveness ratios for the treatment (saxagliptin+metformin) a...
<p>Superior regimens are lower in cost (toward the left) and greater in efficacy (toward the top). I...
Cost-effectiveness acceptability curve for relapse of recurrence showing the probability that S-PCT ...
<p>Scatter plot of incremental cost against incremental QALYs of ribotype-guided FMT versus vancomyc...
<p>Cost-effectiveness acceptability curves showing the probability that PCM plus TENS is cost effect...
Purpose: To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in firs...
<p>(A) The graph plots the incremental discounted QALYs (<i>y</i>-axis) and incremental discounted l...
<p>Cost-effectiveness acceptability curves for PCV10, PCV13 and no vaccination in the scenarios of u...
textabstractBackground Costly biologicals in palliative oncology are emerging at a rapid pace. For e...
<p>The cost-effectiveness scatterplot shows incremental costs (€) versus incremental effectiveness e...
<p>The figure shows the distribution of cost-effectiveness pairs on the cost-effectiveness plane.</p
<p>The figure displays the incremental HbA1c (x axis) and incremental cost (y axis) outcomes of 5,00...
Cost-effectiveness acceptability curve for regorafenib treatment in the overall sample.</p
<p>Cost-effectiveness acceptability curve showing the probability that golimumab with standard care ...
<p>Acceptability curves of the cost-effectiveness at the different ceiling threshold of four treatme...
<p>Scatter plot of incremental cost-effectiveness ratios for the treatment (saxagliptin+metformin) a...
<p>Superior regimens are lower in cost (toward the left) and greater in efficacy (toward the top). I...
Cost-effectiveness acceptability curve for relapse of recurrence showing the probability that S-PCT ...
<p>Scatter plot of incremental cost against incremental QALYs of ribotype-guided FMT versus vancomyc...
<p>Cost-effectiveness acceptability curves showing the probability that PCM plus TENS is cost effect...
Purpose: To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in firs...
<p>(A) The graph plots the incremental discounted QALYs (<i>y</i>-axis) and incremental discounted l...
<p>Cost-effectiveness acceptability curves for PCV10, PCV13 and no vaccination in the scenarios of u...
textabstractBackground Costly biologicals in palliative oncology are emerging at a rapid pace. For e...
<p>The cost-effectiveness scatterplot shows incremental costs (€) versus incremental effectiveness e...
<p>The figure shows the distribution of cost-effectiveness pairs on the cost-effectiveness plane.</p